Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant.
about
Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Preliminary evidence that the ...... can act as a mucosal adjuvant.
@ast
Preliminary evidence that the ...... can act as a mucosal adjuvant.
@en
type
label
Preliminary evidence that the ...... can act as a mucosal adjuvant.
@ast
Preliminary evidence that the ...... can act as a mucosal adjuvant.
@en
prefLabel
Preliminary evidence that the ...... can act as a mucosal adjuvant.
@ast
Preliminary evidence that the ...... can act as a mucosal adjuvant.
@en
P2093
P2860
P1433
P1476
Preliminary evidence that the ...... can act as a mucosal adjuvant
@en
P2093
Bala Vamsi K Karuturi
Joy A Phillips
Sam D Sanderson
P2860
P304
P356
10.1016/J.CLIM.2015.06.006
P577
2015-06-23T00:00:00Z